Endoscopic Findings of Checkpoint Inhibitor-induced Ileitis with Use of the Latest Advanced Endoscopic Optical Diagnosis: Near-focus Narrow-band Imaging
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Ferretti F, Cannatelli R, Maconi G, Ardizzone S Cancers (Basel). 2023; 15(2).
PMID: 36672491 PMC: 9856548. DOI: 10.3390/cancers15020542.
Schiepatti A, Premoli A, Maimaris S, Rizzo M, Marples M, Villani L Drugs Context. 2022; 11.
PMID: 36339292 PMC: 9616105. DOI: 10.7573/dic.2022-6-3.
Shivaji U, Jeffery L, Gui X, Smith S, Ahmad O, Akbar A Therap Adv Gastroenterol. 2019; 12:1756284819884196.
PMID: 31723355 PMC: 6831976. DOI: 10.1177/1756284819884196.
References
1.
Johnston R, Lutzky J, Chodhry A, Barkin J
. Cytotoxic T-lymphocyte-associated antigen 4 antibody-induced colitis and its management with infliximab. Dig Dis Sci. 2008; 54(11):2538-40.
DOI: 10.1007/s10620-008-0641-z.
View
2.
Gonzalez R, Salaria S, Bohannon C, Huber A, Feely M, Shi C
. PD-1 inhibitor gastroenterocolitis: case series and appraisal of 'immunomodulatory gastroenterocolitis'. Histopathology. 2016; 70(4):558-567.
DOI: 10.1111/his.13118.
View
3.
Jain A, Lipson E, Sharfman W, Brant S, Lazarev M
. Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis. World J Gastroenterol. 2017; 23(11):2023-2028.
PMC: 5360643.
DOI: 10.3748/wjg.v23.i11.2023.
View
4.
Prieux-Klotz C, Dior M, Damotte D, Dreanic J, Brieau B, Brezault C
. Immune Checkpoint Inhibitor-Induced Colitis: Diagnosis and Management. Target Oncol. 2017; 12(3):301-308.
DOI: 10.1007/s11523-017-0495-4.
View
5.
Bertha M, Bellaguara E, Kuzel T, Hanauer S
. Checkpoint Inhibitor-Induced Colitis: A New Type of Inflammatory Bowel Disease?. ACG Case Rep J. 2017; 4:e112.
PMC: 5636906.
DOI: 10.14309/crj.2017.112.
View